Selected research
Market Outlook & Growth Opportunities
Global Midostaurin Market Outlook and Growth Opportunities 2026
Market perspective
The global Midostaurin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Midostaurin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Midostaurin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Midostaurin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Midostaurin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Midostaurin market include Novartis. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Midostaurin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Midostaurin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Midostaurin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Midostaurin market size, projected growth trends, production technologies, key applications, and end-use industries.
Midostaurin Segment by Company
Novartis
Midostaurin Segment by Type
AML
MDS
Other
Midostaurin Segment by Application
Hospital
Pharmacy
Midostaurin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Midostaurin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Midostaurin market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Midostaurin significant trends, drivers, influence factors in global and regions.
6. To analyze Midostaurin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Midostaurin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Midostaurin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Midostaurin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Midostaurin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Midostaurin industry.
Chapter 3: Detailed analysis of Midostaurin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Midostaurin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Midostaurin in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- AML
- MDS
- Other
Applications
- Hospital
- Pharmacy
Companies covered
- Novartis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Midostaurin Sales Value (2021-2032)
- 1.2.2 Global Midostaurin Sales Volume (2021-2032)
- 1.2.3 Global Midostaurin Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Midostaurin Market Dynamics
- 2.1 Midostaurin Industry Trends
- 2.2 Midostaurin Industry Drivers
- 2.3 Midostaurin Industry Opportunities and Challenges
- 2.4 Midostaurin Industry Restraints
3 Midostaurin Market by Company
- 3.1 Global Midostaurin Company Revenue Ranking in 2025
- 3.2 Global Midostaurin Revenue by Company (2021-2026)
- 3.3 Global Midostaurin Sales Volume by Company (2021-2026)
- 3.4 Global Midostaurin Average Price by Company (2021-2026)
- 3.5 Global Midostaurin Company Ranking (2024-2026)
- 3.6 Global Midostaurin Company Manufacturing Base and Headquarters
- 3.7 Global Midostaurin Company Product Type and Application
- 3.8 Global Midostaurin Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Midostaurin Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Midostaurin Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Midostaurin Market by Type
- 4.1 Midostaurin Type Introduction
- 4.1.1 AML
- 4.1.2 MDS
- 4.1.3 Other
- 4.2 Global Midostaurin Sales Volume by Type
- 4.2.1 Global Midostaurin Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Midostaurin Sales Volume by Type (2021-2032)
- 4.2.3 Global Midostaurin Sales Volume Share by Type (2021-2032)
- 4.3 Global Midostaurin Sales Value by Type
- 4.3.1 Global Midostaurin Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Midostaurin Sales Value by Type (2021-2032)
- 4.3.3 Global Midostaurin Sales Value Share by Type (2021-2032)
5 Midostaurin Market by Application
- 5.1 Midostaurin Application Introduction
- 5.1.1 Hospital
- 5.1.2 Pharmacy
- 5.2 Global Midostaurin Sales Volume by Application
- 5.2.1 Global Midostaurin Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Midostaurin Sales Volume by Application (2021-2032)
- 5.2.3 Global Midostaurin Sales Volume Share by Application (2021-2032)
- 5.3 Global Midostaurin Sales Value by Application
- 5.3.1 Global Midostaurin Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Midostaurin Sales Value by Application (2021-2032)
- 5.3.3 Global Midostaurin Sales Value Share by Application (2021-2032)
6 Midostaurin Regional Sales and Value Analysis
- 6.1 Global Midostaurin Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Midostaurin Sales by Region (2021-2032)
- 6.2.1 Global Midostaurin Sales by Region: 2021-2026
- 6.2.2 Global Midostaurin Sales by Region (2027-2032)
- 6.3 Global Midostaurin Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Midostaurin Sales Value by Region (2021-2032)
- 6.4.1 Global Midostaurin Sales Value by Region: 2021-2026
- 6.4.2 Global Midostaurin Sales Value by Region (2027-2032)
- 6.5 Global Midostaurin Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Midostaurin Sales Value (2021-2032)
- 6.6.2 North America Midostaurin Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Midostaurin Sales Value (2021-2032)
- 6.7.2 Europe Midostaurin Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Midostaurin Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Midostaurin Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Midostaurin Sales Value (2021-2032)
- 6.9.2 South America Midostaurin Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Midostaurin Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Midostaurin Sales Value Share by Country, 2025 VS 2032
7 Midostaurin Country-level Sales and Value Analysis
- 7.1 Global Midostaurin Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Midostaurin Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Midostaurin Sales by Country (2021-2032)
- 7.3.1 Global Midostaurin Sales by Country (2021-2026)
- 7.3.2 Global Midostaurin Sales by Country (2027-2032)
- 7.4 Global Midostaurin Sales Value by Country (2021-2032)
- 7.4.1 Global Midostaurin Sales Value by Country (2021-2026)
- 7.4.2 Global Midostaurin Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Midostaurin Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Midostaurin Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Midostaurin Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Midostaurin Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Midostaurin Sales Value Growth Rate (2021-2032)
- 7.9.2 France Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Midostaurin Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Midostaurin Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Midostaurin Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Midostaurin Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Midostaurin Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Midostaurin Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Midostaurin Sales Value Growth Rate (2021-2032)
- 7.16.2 China Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Midostaurin Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Midostaurin Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Midostaurin Sales Value Growth Rate (2021-2032)
- 7.19.2 India Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Midostaurin Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Midostaurin Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Midostaurin Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Midostaurin Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Midostaurin Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Midostaurin Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Midostaurin Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Midostaurin Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Midostaurin Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Midostaurin Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Midostaurin Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Midostaurin Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Midostaurin Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Midostaurin Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Midostaurin Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Midostaurin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Novartis
- 8.1.1 Novartis Company Information
- 8.1.2 Novartis Business Overview
- 8.1.3 Novartis Midostaurin Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Novartis Midostaurin Product Portfolio
- 8.1.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Midostaurin Value Chain Analysis
- 9.1.1 Midostaurin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Midostaurin Sales Mode & Process
- 9.2 Midostaurin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Midostaurin Distributors
- 9.2.3 Midostaurin Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst